AWH

Aspira Women`s Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.440
+0.060
+1.37%
After Hours: 4.440 0 0.00% 16:34 08/07 EDT
OPEN
4.360
PREV CLOSE
4.380
HIGH
4.560
LOW
4.325
VOLUME
444.27K
TURNOVER
--
52 WEEK HIGH
5.78
52 WEEK LOW
0.3506
MARKET CAP
432.36M
P/E (TTM)
-26.3033
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AWH stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.

EPS

AWH News

More
Aspira Women’s Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th
AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for the second quarter ended June 30, 2020 on Thursday, August 13, 2020 a
GlobeNewswire · 07/31 13:23
Insider Buying: Jack Schuler Just Spent US$8.0m On Aspira Women's Health Inc. (NASDAQ:AWH) Shares
Simply Wall St. · 07/08 11:30
Aspira Women’s Health Inc. Announces Equity Financing of Approximately $11 Million
The closing of the private placement is expected to occur on July 6, 2020, subject to customary closing conditions. At the closing, ASPIRA will receive approximately $11 million in gross proceeds, before transaction costs. ASPIRA intends to use the net proce
GlobeNewswire · 07/01 15:23
Aspira Women’s Health, Inc. Announces First Patient Enrolled in Prospective OVANex Study for Benign Pelvic Mass Monitoring
Aspira Women’s Health, Inc. (AWH), a bioanalytical-based women’s health company, today announced the first patient enrolled in a national clinical study of benign pelvic mass management. The study will enroll over 1,000 women for assessing ovarian cancer risk
GlobeNewswire · 06/29 12:00
Vermillion, Inc. Announces Rebranding and Company Name Change to Aspira Womens Health Inc.
GlobeNewswire · 06/11 13:31
Vermillion changes its name to Aspira Women’s Health Inc.
Seeking Alpha - Article · 06/11 12:49
Vermillion Reports Will Rebrand, Change Corporate Name to Aspira Women's Health, Will Trade Under Ticker 'AWH'
Benzinga · 06/11 12:41
Why Vermillion's Stock Is Trading Higher Today
Vermillion, Inc. (NASDAQ: VRML) shares were trading higher on Wednesday, after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus, including coronavirus antibody testings. The company is also expected to join the Ru
Benzinga · 06/10 15:06

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About AWH

Aspira Women’s Health Inc., formerly Vermillion, Inc., is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. The Company sells OVA1, Overa and OVA1PLUS risk of malignancy tests for ovarian cancer. The Company also sells a product for genetic testing for specific women’s health diseases, called ASPiRA GenetiX, with a core focus on ovarian cancer. OVA1 is a blood test designed to, in addition to a physician’s clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor before planned surgery. The Overa is a second-generation biomarker panel intended to maintain its product’s sensitivity while improving specificity. OVA1PLUS is a service offering combining its OVA1 and Overa products, designed to enhance accuracy and reduce false elevations in the intermediate-risk area.
More

Webull offers kinds of Aspira Women's Health Inc stock information, including NASDAQ:AWH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AWH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AWH stock methods without spending real money on the virtual paper trading platform.